This inventor holds 1 USPTO granted patent. Top assignee: Leland Stanford Junior University. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Innovations by Mary M Chen in Heart Failure Treatment
Introduction
Mary M Chen is a notable inventor based in Fremont, CA (US). She has made significant contributions to the field of medical science, particularly in the treatment of heart failure. Her innovative approach has led to the development of a unique method that addresses critical health issues associated with cardiovascular diseases.
Latest Patents
Mary M Chen holds 1 patent for her invention titled "Apelin and uses thereof." This patent provides a method for treating or preventing heart failure or related conditions. The invention involves administering an effective dose of an apelin peptide or APJ receptor ligand to the subject. In certain embodiments, the apelin peptide is administered chronically, which is crucial for improving hemodynamic parameters or prognostic variables for heart failure. The clinical conditions associated with heart failure that her invention addresses include atherosclerosis, restenosis, ischemic cardiovascular diseases, and idiopathic or viral cardiomyopathy.
Career Highlights
Mary M Chen is affiliated with Leland Stanford Junior University, where she continues her research and development in the medical field. Her work has garnered attention for its potential impact on treating heart failure, a condition that affects millions worldwide.
Collaborations
Mary has collaborated with esteemed colleagues such as Euan A Ashley and Thomas Quertermous. Their combined expertise enhances the research and development of innovative solutions in cardiovascular health.
Conclusion
Mary M Chen's contributions to heart failure treatment through her innovative patent demonstrate her commitment to advancing medical science. Her work not only addresses critical health issues but also paves the way for future research in this vital area.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
